This is an old revision of the document!
Jeremy Grimshaw
Dr. Jeremy M. Grimshaw, MBChB, PhD, FRCGP, FCAHS is a Canadian health information specialist and epidemiologist based in Ottawa, Ontario.
Grimshaw is a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake.1)
Education
- Faculty of Medicine, University of Edinburgh, 1979 - 1984
- Faculty of Medicine, University of Aberdeen, 1989 - 1997
Career and Affiliations
Canadian Academy of Health Sciences
Grimshaw is a fellow of the Canadian Academy of Health Sciences.2)
University of Ottawa
Grimshaw is a professor in the Department of Medicine at the University of Ottawa.3)
Campbell Collaboration
Grimshaw is the President of the Board of the Directors of the Campbell Collaboration.4)
He was initially elected as co-chair in 2016.5)
The Ottawa Hospital
Grimshaw is a Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute.6)
Eastern Ontario Regional Laboratory Association
Grimshaw sits on the board of directors at the Eastern Ontario Regional Laboratory Association.7)
AcademyHealth
Grimshaw has been a presenter for AcademyHealth.8)
Ontario COVID-19 Science Advisory Table
Grimshaw is a member of the Behavioural Science Working Group of the Ontario COVID-19 Science Advisory Table.9)
Research
Grimshaw received a strategic grant from the Cardiac Arrhythmia Network of Canada for a study titled “Decreasing Hospital Admissions from the Emergency Department for Acute Atrial Fibrillation”.10) CANC is partnered with many organizations with interest in COVID-19 including Apotex, Bayer, Boehringer Ingelheim, IBM, Johnson & Johnson, LifeLabs, Medtronic, Pfizer, and St. Jude Medical (an Abbott company).11)
COVID-19
Grimshaw is a co-Principal Investigator and co-Chair of the COVID-END study, funded by the Canadian Institutes of Health Research (CIHR).12) He is also a member of the Canadian secretariat.13)
Diabetes
Grimshaw received an operating grant from as a co-Principal Investigator from Diabetes Action Canada for a study called “An implementation science approach to increase attendance to retinopathy screening by people with diabetes.”14) DAC is funded by AstraZeneca, Bayer, Merck and Sun Life Financial.15)
Awards and Recognition
Grimshaw was recognized as a Thomson Reuters Highly Cited Researcher in 2015, 2016 2017 and 2018.16) 17)